Evidence map›Paper›PMID 35667963›Full record

ArticleJournal of diabetes and its complications2022

Memory complaints moderate the concordance between self-report and electronically monitored adherence in adults with type 2 diabetes.

Amit Shapira, Naomi S Kane, Molly L Tanenbaum, Claire J Hoogendoorn, Jeffrey S Gonzalez

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes and its complications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Amit ShapiraJoslin Diabetes Center, Harvard Medical School, Boston, MA.
Naomi S KaneVA Ann Arbor Healthcare System, Michigan Medicine, Department of Psychiatry, Ann Arbor, MI.
Molly L TanenbaumDepartment of Pediatrics, Stanford University School of Medicine, Palo Alto, CA.
Claire J HoogendoornFerkauf Graduate School of Psychology, Yeshiva University, Bronx, NY.
Jeffrey S GonzalezFerkauf Graduate School of Psychology, Yeshiva University, Bronx, NY; Departments of Medicine (Endocrinology) and Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY. Electronic address: jeffrey.gonzalez@yu.edu.
Albert Einstein College of Medicine · USJoslin Diabetes Center · USStanford University · USVA Ann Arbor Healthcare System · USYeshiva University · US

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY E. PESSIN · 2015 to 2026
$27.7M
TRAINING IN DIABETES AND METABOLISMT32DK007260 · NIDDK · JOSLIN DIABETES CENTER · PI LAURIE J GOODYEAR · 1986 to 2026
$13.6M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
Power-Up Study Administrative Supplement to Promote DiversityR01DK121896 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CHAMBERS, EARLE C, GONZALEZ, JEFFREY S · 2019 to 2023
$3.6M
Emotional Distress in a Comparative Effectiveness Trial of Diabetes TreatmentsR01DK104845 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI CHERRINGTON, ANDREA L, GONZALEZ, JEFFREY S · 2015 to 2019
$3.4M
Function and Emotion in Everyday Life with Type 1 Diabetes: FEEL-T1DR01DK121298 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GONZALEZ, JEFFREY S, PYATAK, ELIZABETH F · 2019 to 2022
$3.2M
ONBOARD: OvercomiNg Barriers & Obstacles to Adopting Diabetes DevicesK23DK119470 · NIDDK · STANFORD UNIVERSITY · PI TANENBAUM, MOLLY LEAH · 2019 to 2023
$988k
NIDDK NIH HHS K23 DK119470NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK111022NIDDK NIH HHS R01 DK104845NIDDK NIH HHS R01 DK121298NIDDK NIH HHS R01 DK121896NIDDK NIH HHS T32 DK007260
6 · The paper itself

Abstract

aimsWe examined the impact of memory complaints on the concordance between self-report (SR) and electronically monitored (EM) medication adherence, independent of depression symptoms, among adults with type 2 diabetes (T2D).

methodsAdults (N = 104, age = 56.6 ± 9.2; 64% female) completed a prospective and retrospective memory questionnaire (PRMQ) and a depression symptom interview at baseline. EM was tracked over 3 months and participants rated adherence using SR. Multiple linear regression evaluated PRMQ as a moderator of the relationship between EM and SR, adjusting for depression and other covariates.

resultsPRMQ was correlated with lower SR (r = -0.31, p = 0.001), but not with EM. PRMQ moderated the relationship between SR and EM, independent of depression symptoms. At low levels of PRMQ, SR and EM were closely related (β = 0.76, p < 0.001); at high levels of PRMQ the relationship was weaker (β = 0.28, p = 0.02). Participants who under-reported their adherence (SR < EM) had higher PRMQ scores than more concordant reporters (p = 0.016).

conclusionsSR and EM measures were less concordant among adults with T2D who endorsed higher PRMQ scores. Memory complaints may contribute to under-reporting of medication adherence in adults with T2D.

Indexed as

Diabetes Mellitus, Type 2AdultAgedFemaleHumansMaleMedication AdherenceMiddle AgedProspective StudiesRetrospective StudiesSelf ReportSurveys and QuestionnairesDepression symptomsElectronically recorded memory complaintsMedication adherenceSelf-reportType 2 diabetesValidity

Identifiers

PMID35667963
PMCPMC10290887
OpenAlexW4225330021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.